Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation. Left: Lactobacillus bulgaricus / Right: Streptococcus thermophilus from the Japanese marketing page for Meiji’s R-1 yogurt line. Immunotherapy has transformed lung cancer treatment, significantly improving patients’ treatment prospects . But gaps remain. In non-small cell lung cancer, 27 to 46% of patients respond to initial checkpoint inhibitor therapy, and of those who do, the majority develop resistance within four years, according to a study in Cancers 2024 . What if a natural polymer produced by a probiotic strain could help tilt those odds?…
Immunotherapy has transformed lung cancer treatment, significantly improving patients’ treatment prospects. But gaps remain. In non-small cell lung cancer, 27 to 46% of patients respond to initial checkpoint inhibitor therapy, and of those who do, the majority develop resistance within four years, according to a study in Cancers 2024. What if a natural polymer produced…
The post Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer appeared first on Drug Discovery and Development.
US Pharma Marketing